1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Rationale and design of INFINITY-SWEDEHEART : A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
(
- Contribution to journal › Article
-
Mark
Uso de registros cardiovasculares en procesos regulatorios : perspectivas del Colaboratorio Cardiovascular EU-MDR
(
- Contribution to journal › Scientific review
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
(
- Contribution to journal › Article
-
Mark
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART) : a single-blind, non-inferiority, registry-based, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
(
- Contribution to journal › Article
- 2023
-
Mark
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
(
- Contribution to journal › Article
-
Mark
Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction : The Perfect-CR study
(
- Contribution to journal › Article
-
Mark
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients : PROSPECT II
(
- Contribution to journal › Article
- 2021
-
Mark
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II) : a prospective natural history study
(
- Contribution to journal › Article
- 2020
-
Mark
Attending Heart School and long-term outcome after myocardial infarction : A decennial SWEDEHEART registry study
(
- Contribution to journal › Article